DATED [•], 2020 SUMMIT THERAPEUTICS INC. and [CONSULTANT] WARRANT AGREEMENTWarrant Agreement • September 28th, 2020 • Zanganeh Maky • Pharmaceutical preparations • Delaware
JOINT FILING AGREEMENTJoint Filing Agreement • September 28th, 2020 • Zanganeh Maky • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.01 per share, of Summit Therapeutics Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
ContractZanganeh Maky • September 28th, 2020 • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE WARRANT SHARES TO BE ISSUED UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH HEREIN, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
